{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-133322","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.611130+00:00","generated_at":"2026-06-02T17:37:28.065398+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Soleno Therapeutics prices $138M public offering of 3M shares at $46/share","bullets":["Public offering of 3,000,000 shares at $46.00 per share for gross proceeds of ~$138M.","Net proceeds estimated at ~$129.3M after underwriting discounts and expenses.","Underwriters granted 30-day option to purchase up to 450,000 additional shares.","Proceeds to fund R&D for DCCR (Prader-Willi Syndrome) and general corporate purposes.","Offering expected to close on or about May 7, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-133322","json":"https://secwatch.observer/filing/0001193125-24-133322.json","markdown":"https://secwatch.observer/filing/0001193125-24-133322.md","text":"https://secwatch.observer/filing/0001193125-24-133322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524133322/0001193125-24-133322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524133322/d808535d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T17:37:28.065398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}